Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
MONTREAL, May 25, 2006 (PRIMEZONE) -- Dr. Jean-Marie Dupuy, President and Chief Executive Officer of Viropro Inc. ("Viropro" or "the company") (OTCBB:VPRO), today announced the creation of Theravax...
-
MONTREAL, May 23, 2006 (PRIMEZONE) -- Viropro Inc. ("Viropro" or "The Company") (OTCBB:VPRO), a company constantly solidifying its reputation as an international expert in the production and set-up of...
-
MONTREAL, May 9, 2006 (PRIMEZONE) -- Viropro Inc. ("Viropro" or "The Company") (OTCBB:VPRO) is rapidly solidifying its reputation as an international expert in the production and set-up of technology...
-
Viropro Teams Up With Parteurop: A World Renowned Firm Specializing in the Bio-Pharmaceutical Domain
MONTREAL, April 20, 2006 (PRIMEZONE) -- Viropro Inc. ("Viropro" or "The Company") (OTCBB:VPRO) announced today the signing of a contract for collaboration with the French consulting firm Parteurop,...
-
MONTREAL, April 11, 2006 (PRIMEZONE) -- Today, Jean-Marie Dupuy, Chief Executive Officer of Viropro Inc., -- "Viropro" or "the company" (OTCBB:VPRO) -- is proud to announce the signing of a new...
-
MONTREAL, April 10, 2006 (PRIMEZONE) -- Viropro Inc. ("Viropro" or "The Company") (OTCBB:VPRO) has filed its annual financial report with the SEC, thereby terminating the temporary change of the...
-
MONTREAL, March 20, 2006 (PRIMEZONE) -- Viropro Inc. ("Viropro" or "The Company") (OTCBB:VPROE) sought to clarify the status of its SEC requisite filings that have been delayed due to recent...
-
MONTREAL, March 2, 2006 (PRIMEZONE) -- Dr Jean-Marc Dupuy, Chief Executive Officer of Viropro Inc., "Viropro" or "the company" (OTCBB:VPRO) is pleased to announce that Viropro has concluded a...
-
MONTREAL, Feb. 22, 2006 (PRIMEZONE) -- Viropro, Inc. (OTCBB:VPRO) -- an expert in the development and transfer of technologies for biogeneric recombinant products -- is proud to announce that it has...
-
Objectives of this financing: -- Attain profitability and revenue objectives for 2006 -- Accelerate business development of Viropro on international markets -- Maximize investors' stock...